Front Page News

Cure SMA Funds $2 Million in New Research in 2015-2016

June 18, 2016
Posted in , ,

Over the past few months, Cure SMA has announced a total of just over $2 million in new research funding. Our model is designed to […]

Read More ›

The 2016 Annual SMA Conference is Here!

June 14, 2016
Posted in , ,

The 2016 Annual SMA Conference, now in its 28th year, is set to kick off on June 16 and continue into a weekend full of […]

Read More ›

Cure SMA Awards $304,000 Drug Discovery Grant to Livio Pellizzoni, PhD, at Columbia University

June 13, 2016
Posted in ,

Cure SMA has awarded a $304,000 drug discovery grant to Livio Pellizzoni, PhD, at Columbia University. The award is for the project, “Pharmacological Inhibition of […]

Read More ›

Cure SMA Receives 2016 NIH Grant

June 10, 2016
Posted in , ,

For the eighth consecutive year, Cure SMA has received a grant from the National Institutes of Health (NIH) for the SMA Researcher Meeting. This year’s […]

Read More ›

Cure SMA Announces Biogen as Presenting Sponsor for the 2016 Annual SMA Conference

June 8, 2016
Posted in ,

Cure SMA is pleased to announce that Biogen will be the Presenting Sponsor for our 2016 Annual SMA Conference. This year’s conference is set to […]

Read More ›

Cure SMA Releases June 2016 Update to the SMA Drug Pipeline

June 7, 2016
Posted in , , ,

We’ve recently released an update to the SMA drug pipeline. This latest version includes: 18 active programs. 14 pharmaceutical partners. 6 programs in clinical trials. […]

Read More ›

Thank you to Our 2016 Annual SMA Conference Exhibitors!

June 6, 2016
Posted in ,

Thank you to the following exhibitors who have generously supported our 2016 Annual SMA Conference. This one-of-a-kind event would not be possible without your support! […]

Read More ›

Biogen and Ionis Release Spring 2016 Community Update

June 3, 2016
Posted in ,

Biogen and Ionis Pharmaceuticals recently provided an update on the clinical development of nusinersen (IONIS-SMNRx), which is currently being tested in Phase 3 clinical trials: […]

Read More ›

2016 Update on SMA-FDA Interactions

June 1, 2016
Posted in , ,

The SMA drug pipeline has grown dramatically in just over a decade. Of the 18 programs in the pipeline, six of these are in clinical […]

Read More ›

2016 Annual SMA Conference Booklet Now Posted

May 31, 2016
Posted in ,

The 2016 Annual SMA Conference Booklet has been posted. The booklet includes: A complete schedule with information about the special events we’ve got planned for […]

Read More ›
Scroll to Top